Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5575
Gene Symbol: PRKAR1B
PRKAR1B
0.120 Biomarker disease HPO
Entrez Id: 8398
Gene Symbol: PLA2G6
PLA2G6
0.100 Biomarker disease HPO
Entrez Id: 23503
Gene Symbol: ZFYVE26
ZFYVE26
0.100 Biomarker disease HPO
Entrez Id: 4208
Gene Symbol: MEF2C
MEF2C
0.100 GeneticVariation disease CLINVAR
Entrez Id: 54205
Gene Symbol: CYCS
CYCS
0.010 Biomarker disease BEFREE <b>Abbreviations:</b> 4HPR: 4-hydroxy(phenyl)retinamide; AKT: AKT1 serine/threonine kinase 1; ALS: amyotrophic lateral sclerosis; ATG: autophagy related; AVs: autophagic vesicle; C9orf72: chromosome 9 open reading frame 72; CASP3: caspase 3; CHAT: choline O-acetyltransferase; CYCS: cytochrome c, somatic; DIV: day in vitro; FTD: frontotemporal dementia; FUS: FUS RNA binding protein; GFP: green fluorescent protein; hiPSCs: human induced pluripotent stem cells; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MNs: motoneurons; mRFP: monomeric red fluorescent protein; MTOR: mechanistic target of rapamycin kinase; NFE2L2/NRF2: nuclear factor, erythroid 2 like 2; RARA: retinoic acid receptor alpha; SLC18A3/VACHT: solute carrier family 18 (vesicular acetylcholine transporter), member 3; SQSTM1/p62: sequestosome 1; TBK1: TANK binding kinase 1; TEM: transmission electron microscopy. 30939964 2019
Entrez Id: 2521
Gene Symbol: FUS
FUS
0.200 AlteredExpression disease BEFREE <b>Abbreviations:</b> 4HPR: 4-hydroxy(phenyl)retinamide; AKT: AKT1 serine/threonine kinase 1; ALS: amyotrophic lateral sclerosis; ATG: autophagy related; AVs: autophagic vesicle; C9orf72: chromosome 9 open reading frame 72; CASP3: caspase 3; CHAT: choline O-acetyltransferase; CYCS: cytochrome c, somatic; DIV: day in vitro; FTD: frontotemporal dementia; FUS: FUS RNA binding protein; GFP: green fluorescent protein; hiPSCs: human induced pluripotent stem cells; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MNs: motoneurons; mRFP: monomeric red fluorescent protein; MTOR: mechanistic target of rapamycin kinase; NFE2L2/NRF2: nuclear factor, erythroid 2 like 2; RARA: retinoic acid receptor alpha; SLC18A3/VACHT: solute carrier family 18 (vesicular acetylcholine transporter), member 3; SQSTM1/p62: sequestosome 1; TBK1: TANK binding kinase 1; TEM: transmission electron microscopy. 30939964 2019
Entrez Id: 1509
Gene Symbol: CTSD
CTSD
0.040 Biomarker disease BEFREE <b>Abbreviations:</b> ALS: amyotrophic lateral sclerosis; ANOVA: analysis of variance; ChAT: choline acetyltransferase; CTSD: cathepsin D; FTD: frontotemporal dementia; LAMP1: lysosomal associated membrane protein 1; NMJ: neuromuscular junction; RBFOX3/NeuN: RNA binding fox-1 homolog 3; SQSTM1: sequestosome 1; TARDBP/TDP-43: TAR DNA binding protein 43. 31242080 2020
Entrez Id: 6647
Gene Symbol: SOD1
SOD1
0.100 GeneticVariation disease BEFREE <b>Background:</b> Pathogenic variants in ALS genes are known to be present in up to 70% of familial and 10% of apparently sporadic ALS cases, and can be associated with risks for ALS only, or risks for other neurodegenerative diseases (eg. frontotemporal dementia). 31702461 2019
Entrez Id: 3483
Gene Symbol: IGFALS
IGFALS
0.100 GeneticVariation disease BEFREE <b>Background:</b> Pathogenic variants in ALS genes are known to be present in up to 70% of familial and 10% of apparently sporadic ALS cases, and can be associated with risks for ALS only, or risks for other neurodegenerative diseases (eg. frontotemporal dementia). 31702461 2019
Entrez Id: 23435
Gene Symbol: TARDBP
TARDBP
0.700 GeneticVariation disease BEFREE <b>Background:</b> The neuropathology of patients with frontotemporal dementia (FTD) or amyotrophic lateral sclerosis (ALS) due to a <i>C9orf72</i> mutation is characterized by two distinct types of characteristic protein depositions containing either TDP-43 or so-called dipeptide repeat proteins that extend beyond frontal and temporal regions. 29599716 2018
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.100 AlteredExpression disease BEFREE <b>Results:</b> Plasma α-synuclein level was significantly increased in patients with PD and APS when compared with controls and FTD without parkinsonism (<i>p</i> < 0.01). 29755341 2018
Entrez Id: 8148
Gene Symbol: TAF15
TAF15
0.020 Biomarker disease BEFREE <i>Cabeza</i> (<i>caz</i>) is the single <i>Drosophila melanogaster</i> orthologue of the human FET proteins FUS, TAF15, and EWSR1, which have been implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. 30209068 2018
Entrez Id: 2130
Gene Symbol: EWSR1
EWSR1
0.030 Biomarker disease BEFREE <i>Cabeza</i> (<i>caz</i>) is the single <i>Drosophila melanogaster</i> orthologue of the human FET proteins FUS, TAF15, and EWSR1, which have been implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. 30209068 2018
Entrez Id: 23435
Gene Symbol: TARDBP
TARDBP
0.700 Biomarker disease BEFREE <sup>18</sup>F-Flortaucipir in TDP-43 associated frontotemporal dementia. 30988363 2019
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.800 GeneticVariation disease BEFREE 'Microtubule-associated protein tau' (MAPT), 'granulin' (GRN) and 'chromosome 9 open reading frame72' (C9ORF72) gene mutations are the major known genetic causes of frontotemporal dementia (FTD). 27632209 2016
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 GeneticVariation disease BEFREE 'Microtubule-associated protein tau' (MAPT), 'granulin' (GRN) and 'chromosome 9 open reading frame72' (C9ORF72) gene mutations are the major known genetic causes of frontotemporal dementia (FTD). 27632209 2016
Entrez Id: 23435
Gene Symbol: TARDBP
TARDBP
0.700 Biomarker disease BEFREE (1) Degeneration of white matter in sporadic FTLD-TDP was characterized by increased vacuolation and GI, (2) pathological changes were topographically distributed, which suggests propagation of pathological TDP-43 in specific groups of fibers, and (3) both white matter pathology and gray matter pathology need to be considered to quantify the pathological "load" in FTLD-TDP.. 28128723 2017
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.800 GeneticVariation disease BEFREE (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.Proc.Natl.Acad.Sci. 16914875 2006
Entrez Id: 246744
Gene Symbol: STH
STH
0.020 GeneticVariation disease BEFREE 220 clinically stabilized patients with schizophrenia were assessed with the Wisconsin Card Sorting Test (WCST) for evaluation of executive functions and compared for STH allele frequency with 48 patients affected by frontotemporal dementia and 47 healthy subjects. 22187337 2012
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.800 GeneticVariation disease BEFREE 30-50% of FTD is familial, and mutations in two genes, microtubule associated protein tau and Progranulin (GRN), account for about half of these cases. 20971753 2011
Entrez Id: 2896
Gene Symbol: GRN
GRN
0.900 Biomarker disease BEFREE : To develop therapeutic strategies to prevent FTD or delay its progression we must understand whether the loss of progranulin leads to the accumulation of TARDBP. 18771956 2008
Entrez Id: 23435
Gene Symbol: TARDBP
TARDBP
0.700 Biomarker disease BEFREE : To develop therapeutic strategies to prevent FTD or delay its progression we must understand whether the loss of progranulin leads to the accumulation of TARDBP. 18771956 2008
Entrez Id: 5663
Gene Symbol: PSEN1
PSEN1
0.800 CausalMutation disease CLINVAR PSEN1 p.Met233Val in a Complex Neurodegenerative Movement and Neuropsychiatric Disorder. 29316780 2018
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.800 GeneticVariation disease BEFREE Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) is an autosomal dominant condition clinically characterized by behavioral, cognitive, and motor disturbances. 10486204 1999
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.800 GeneticVariation disease BEFREE Frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) is a group of related disorders frequently characterized by the formation of tau inclusions in neurons and glial cells. 10627302 2000